These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6180597)

  • 21. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.
    Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S
    J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma.
    Reddigari S; Kaplan AP
    Blood; 1988 May; 71(5):1334-40. PubMed ID: 2451949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assay of kallikrein inhibitors and levels of acetone-activated kallikrein in plasma specimens from reactors to dextran or to contrast media.
    Johansen HT; Hoem NO; Veggeland T; Briseid K
    Int J Tissue React; 1986; 8(3):185-92. PubMed ID: 2430909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Purification and enzyme study of kininogens I and II from human plasma].
    Díaz A; Henriques OB
    Acta Physiol Lat Am; 1976; 26(4):248-53. PubMed ID: 1032268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein.
    Mori K; Nagasawa S
    J Biochem; 1981 May; 89(5):1465-73. PubMed ID: 6168636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Various properties and kinetics of interaction of high and low molecular weight human kininogens with human plasma kallikrein].
    Nartikova VF; Egorova TP; Rets EV; Paskhina TS
    Biokhimiia; 1986 Mar; 51(3):463-71. PubMed ID: 3634630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen.
    Nakayasu T; Nagasawa S
    J Biochem; 1979 Jan; 85(1):249-58. PubMed ID: 104988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assay methods for prekallikrein and kininogens and their applications.
    Uchida Y; Ohishi S; Tanaka K; Harada Y; Ueno A; Katori M; Funahashi S; Hashimoto T; Ueno T; Kodama J
    Adv Exp Med Biol; 1979; 120A():173-84. PubMed ID: 495307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and characterization of rat low molecular weight kininogen.
    Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O; Handa H
    J Biochem; 1984 Jul; 96(1):81-8. PubMed ID: 6238024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The accelerating effect of bovine plasma HMW kininogen on the surface-mediated activation of factor XII: generation of a derivative form (active kininogen) with maximal cofactor activity by limited proteolysis.
    Sugo T; Kato H; Iwanaga S; Fujii S
    Thromb Res; 1981 Nov; 24(4):329-37. PubMed ID: 6917562
    [No Abstract]   [Full Text] [Related]  

  • 32. Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis.
    Schmaier AH; Farber A; Schein R; Sprung C
    J Lab Clin Med; 1988 Aug; 112(2):182-92. PubMed ID: 2456360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylcysteine in rats: inhibition of activation of prekallikrein and factor XII--protection against dextran-induced blood pressure fall.
    Hoem NO; Briseid G
    Pharmacol Toxicol; 1987 Feb; 60(2):140-4. PubMed ID: 2437551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On a plasminogen activator from human plasma.
    Batista AD; Solana GH; Almonte JF
    Thromb Haemost; 1980 Feb; 42(5):1607-14. PubMed ID: 6899948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of an esterolytic and kinin-forming kallikrein-alpha2-macroglobulin complex in human serum by treatment with acetone.
    Vogt V; Dugal B
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul; 294(1):75-84. PubMed ID: 63921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dextran-induced lowering of parameters of the kallikrein-kinin system in rat plasma: significance of monoamine-depleting agents.
    Briseid K; Berstad J
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):169-73. PubMed ID: 506738
    [No Abstract]   [Full Text] [Related]  

  • 38. Independent consumption of high and low molecular weight kininogens in vivo.
    Uchida Y; Katori M
    Adv Exp Med Biol; 1986; 198 Pt A():113-8. PubMed ID: 3812086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
    Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP
    J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of the cleavage of human high molecular weight kininogen by purified plasma and tissue kallikreins, and upon contact activation of plasma.
    Reddigari S; Kaplan AP
    Adv Exp Med Biol; 1989; 247B():317-24. PubMed ID: 2481945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.